Evidence map›Paper›PMID 38765336›Full record

ArticleCureus2024

Interstitial Lung Disease With Respiratory Failure After COVID-19 mRNA Vaccination.

Soichi Maruyama, Taro Takahashi, Daisuke Kobayashi, Yoneko Hayase, Yukihiko Sugiyama

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soichi MaruyamaDepartment of Respiratory Medicine, Nerima Hikarigaoka Hospital, Tokyo, JPN.
Taro TakahashiDepartment of Respiratory Medicine, Nerima Hikarigaoka Hospital, Tokyo, JPN.
Daisuke KobayashiDepartment of Pathology, Nerima Hikarigaoka Hospital, Tokyo, JPN.
Yoneko HayaseDepartment of Pathology, Nerima Hikarigaoka Hospital, Tokyo, JPN.
Yukihiko SugiyamaDepartment of Respiratory Medicine, Nerima Hikarigaoka Hospital, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A septuagenarian woman developed dyspnea on the day following a fifth vaccination. Just before vaccination, a chest X-ray showed no abnormalities, but after the fifth vaccination, bilateral diffuse ground-glass opacities were detected. Bronchoalveolar lavage revealed a lymphocyte predominance and transbronchial lung biopsy revealed growth of the alveolar epithelium, along with organized polypoid granulation tissues in the alveolar ducts and bronchioles. Despite the administration of corticosteroids, imaging revealed persistent fibrosis, and she required long-term oxygen therapy. Although recent reports indicated that corticosteroids are effective for drug-induced interstitial lung disease related to COVID-19 mRNA vaccination, this case presented a somewhat different clinical manifestation.

Indexed as

bronchoscopycovid-19 mrna vaccinedrug-induced interstitial lung disease (di-ild)long-term oxygen therapysteroid

Identifiers

PMID38765336
PMCPMC11101300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.